VIP Clothing Standalone March 2020 Net Sales at Rs 30.55 crore, down 24.08% Y-o-Y
June 29, 2020 / 10:48 AM IST
Reported Standalone quarterly numbers for VIP Clothing are:Net Sales at Rs 30.55 crore in March 2020 down 24.08% from Rs. 40.23 crore in March 2019.
Quarterly Net Loss at Rs. 13.01 crore in March 2020 down 676.13% from Rs. 1.68 crore in March 2019.
EBITDA stands negative at Rs. 2.97 crore in March 2020 down 323.31% from Rs. 1.33 crore in March 2019.
VIP Clothing shares closed at 9.30 on June 26, 2020 (NSE) and has given 16.25% returns over the last 6 months and -47.75% over the last 12 months.
| VIP Clothing | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'20 | Dec'19 | Mar'19 | | Net Sales/Income from operations | 30.55 | 35.14 | 39.16 | | Other Operating Income | -- | -- | 1.07 | | Total Income From Operations | 30.55 | 35.14 | 40.23 | | EXPENDITURE | | Consumption of Raw Materials | 17.45 | 22.98 | 23.93 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.08 | 1.78 | -2.18 | | Power & Fuel | -- | -- | -- | | Employees Cost | 6.34 | 4.93 | 3.95 | | Depreciation | 1.78 | 0.83 | 0.81 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | 0.18 | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 10.33 | 14.73 | 13.58 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -5.27 | -10.11 | -0.03 | | Other Income | 0.51 | 0.17 | 0.55 | | P/L Before Int., Excpt. Items & Tax | -4.75 | -9.95 | 0.52 | | Interest | 3.16 | 2.44 | 2.24 | | P/L Before Exceptional Items & Tax | -7.91 | -12.39 | -1.72 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -7.91 | -12.39 | -1.72 | | Tax | 5.10 | -0.35 | -0.04 | | P/L After Tax from Ordinary Activities | -13.01 | -12.04 | -1.68 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -13.01 | -12.04 | -1.68 | | Equity Share Capital | 16.52 | 16.52 | 16.52 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -1.58 | -1.46 | -0.20 | | Diluted EPS | -1.58 | -1.46 | -0.20 | | EPS After Extra Ordinary | | Basic EPS | -1.58 | -1.46 | -0.20 | | Diluted EPS | -1.58 | -1.46 | -0.20 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
_2020091018165303jzv.jpg "Decoding The World Of ETF")
CBI books UK-based Cambridge Analytica for 'illegally harvesting data' of Facebook users in India Watch more 
Ideas For Profit | Hamara Bajaj: Strong export demand of two-wheelers, long-term positive outlook Watch more 
Bharat Biotech's Covaxin found to be safe, induced immune response in Phase-1 Watch more 
5 die in Serum Institute of India fire in Pune; no impact on Covishield Watch more 
